Seattle Genetics | Stammkapital



Ordinary Share Capital Veränderung Datum
AbbVie USD 18M 0 2024-12
Acadia Pharmaceuticals USD 16K 0 2025-03
Agios Pharmaceuticals USD 74K 1000 2025-03
Amgen USD 33.58B 45M 2025-03
Astellas Pharma JPY 103B 0 2025-03
Bayer EUR 2.52B 0 2025-03
Biogen USD 100K 0 2025-03
BioMarin Pharmaceutical USD 192K 1000 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Celldex Therapeutics USD 66K 0 2025-03
Daiichi Sankyo JPY 50B 0 2025-03
Eisai JPY 44.99B 0 2025-03
Eli Lilly USD 592.6M 200K 2025-03
Exelixis USD 275K 7K 2025-04
Genmab DKK 10M 56M 2025-03
Gilead Sciences USD 1000K 0 2024-12
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Glaxosmithkline GBP 1.35B 0 2024-12
Incyte USD 193K 0 2025-03
Insmed USD 1.82M 25K 2025-03
MacroGenics USD 628K 1000 2024-12
Merck USD 1.79B 0 2025-03
Moderna USD 38.7K 100 2025-03
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
Regeneron Pharmaceuticals USD 0 102K 2025-03
Sarepta Therapeutics USD 10K 0 2025-03
Takeda JPY 1.69T 25M 2025-03
Teva Pharmaceutical Industries USD 58M 0 2024-09
Vertex Pharmaceuticals USD 2.6M 0 2024-12
Xencor USD 712K 9K 2025-03



Seattle Genetics Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.